Literature DB >> 19483522

The high rate of adverse drug events in children receiving prolonged outpatient parenteral antibiotic therapy for osteomyelitis.

Dara Faden1, Howard S Faden.   

Abstract

Forty-five children treated with 82 courses of 15 different antibiotics over 344 weeks during outpatient parenteral antibiotic therapy were evaluated for adverse drug events (ADE). Fifty-one percent of the courses had an associated ADE and 32.5% of the antibiotic courses were discontinued because of ADE. Vancomycin had the highest ADE rate at 85.7% and ceftriaxone had the highest ADE-related discontinuation rate at 66.7%. Cefazolin had the lowest rate of ADE and ADE-related discontinuation rates at 0% for both.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19483522     DOI: 10.1097/INF.0b013e318193ef38

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  Localized mandibular infection affects remote in vivo bioreactor bone generation.

Authors:  Emma Watson; Brandon T Smith; Mollie M Smoak; Alexander M Tatara; Sarita R Shah; Hannah A Pearce; Katie J Hogan; Jonathan Shum; James C Melville; Issa A Hanna; Nagi Demian; Joseph C Wenke; George N Bennett; Jeroen J J P van den Beucken; John A Jansen; Mark E Wong; Antonios G Mikos
Journal:  Biomaterials       Date:  2020-06-23       Impact factor: 12.479

2.  Intravenous versus oral outpatient antibiotic therapy for pediatric acute osteomyelitis.

Authors:  Raymond W Liu; Hadeel Abaza; Priyesh Mehta; Jennifer Bauer; Daniel R Cooperman; Allison Gilmore
Journal:  Iowa Orthop J       Date:  2013

3.  Tolerability of cefazolin after immune-mediated hypersensitivity reactions to nafcillin in the outpatient setting.

Authors:  Kimberly G Blumenthal; Ilan Youngster; Erica S Shenoy; Aleena Banerji; Sandra B Nelson
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

4.  Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy.

Authors:  Kimberly G Blumenthal; Robert A Parker; Erica S Shenoy; Rochelle P Walensky
Journal:  Clin Infect Dis       Date:  2015-05-19       Impact factor: 9.079

Review 5.  The microbiome in early life: implications for health outcomes.

Authors:  Sabrina Tamburini; Nan Shen; Han Chih Wu; Jose C Clemente
Journal:  Nat Med       Date:  2016-07-07       Impact factor: 53.440

6.  Duration of vancomycin treatment for coagulase-negative Staphylococcus sepsis in very low birth weight infants.

Authors:  Nehama Linder; Daniel Lubin; Adriana Hernandez; Limor Amit; Shai Ashkenazi
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

7.  Adverse Events in Pediatric Patients Receiving Long-Term Outpatient Antimicrobials.

Authors:  Scott C Olson; Sherilyn Smith; Scott J Weissman; Matthew P Kronman
Journal:  J Pediatric Infect Dis Soc       Date:  2014-04-30       Impact factor: 3.164

8.  Bone grafts as vancomycin carriers in local therapy of resistant infections.

Authors:  P Melicherčík; D Jahoda; O Nyč; E Klapková; V Barták; I Landor; D Pokorný; T Judl; A Sosna
Journal:  Folia Microbiol (Praha)       Date:  2012-05-16       Impact factor: 2.099

9.  Off-label medicine use in children and adolescents: results of a population-based study in Germany.

Authors:  Hildtraud Knopf; Ingrid-Katharina Wolf; Giselle Sarganas; Wanli Zhuang; Wolfgang Rascher; Antje Neubert
Journal:  BMC Public Health       Date:  2013-07-03       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.